Affordable on-site COVID-19 test using non-powered preconcentrator

Biosens Bioelectron. 2023 Feb 15:222:114965. doi: 10.1016/j.bios.2022.114965. Epub 2022 Dec 2.

Abstract

A simple, affordable point of care test (POCT) is necessary for on-site detection of coronavirus disease 2019 (COVID-19). The lateral flow assay (LFA) has great potential for use in POCT mainly because of factors such as low time consumption, low cost, and ease of use. However, it lacks sensitivity and limits of detection (LOD), which are essential for early diagnostics. In this study, we proposed a non-powered preconcentrator (NPP) based on nanoelectrokinetics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Antigen (Ag) lateral flow assay. The non-powered preconcentrator is composed of glass fiber-based composite paper and ion permselective material, and it can be simply operated by force balancing gravitational, capillary, and depletion-induced forces. The proposed approach helps enrich the SARS-CoV-2 viral nucleocapsid (N) proteins based on a 10-min operation, and it improved the LOD by up to 10-fold. The corresponding virus enrichment, which was evaluated using the reverse-transcriptase polymerase chain reaction (RT-PCR), revealed an improvement in ΔCt values > 3. We successfully demonstrated the enhancement of the NPP-assisted LFA, we extended to applying it to clinical samples. Further, we demonstrated an affordable, easy-to-implement form of LFA by simply designing NPP directly on the LFA buffer tube.

Keywords: COVID-19; Enrichment; LFA; Preconcentrator; SARS-CoV-2; Sample treatment.

MeSH terms

  • Biosensing Techniques*
  • COVID-19 Testing
  • COVID-19* / diagnosis
  • Humans
  • Limit of Detection
  • SARS-CoV-2
  • Sensitivity and Specificity